Pharmaceuticals: who decides the price of life?

This week we are looking back at some of our favourite episodes from 2019. The cystic fibrosis drug Orkambi could extend the lives of thousands of children – but it comes with a price tag of £105,000 per patient per year. In this episode from February, the health editor Sarah Boseley explored how the cost of a life-extending drug could be weighed next to a person’s life. Help support our independent journalism at <a href="https://www.theguardian.com/infocus">theguardian.com/infocus</a>